Home | Welcome to Contract Pharma   
Last Updated Monday, March 30 2015

Print

Breaking News

Gil Roth
June 23, 2011
Injectables CMO cleared for Schedule II through V handling  Read More »
Gil Roth
June 22, 2011
Cancels NDA and MAA and withdraws MS treatment from approved markets  Read More »
Gil Roth
June 22, 2011
Dental, device business sells for $1.8 billion  Read More »
Gil Roth
June 22, 2011
Mitsubishi to gain 20% equity in new bio-CMO network, add global sales and marketing  Read More »
Gil Roth
June 21, 2011
Once-weekly diabetes injection cleared in EU  Read More »
Gil Roth
June 21, 2011
Porsolt and JSW sign a strategic collaboration agreement to co-market contract research services.  Read More »
Gil Roth
June 21, 2011
Will undertake formulation development and clinical testing for RhuDex RA treatment  Read More »
Gil Roth
June 21, 2011
Industry leaders from major pharma and biopharma launch business to help advance development of preclinical candidates  Read More »
Gil Roth
June 21, 2011
Growing demand sparks expansion  Read More »
Gil Roth
June 21, 2011
Leveraging group services and resources can offer client benefits  Read More »
Gil Roth
June 20, 2011
Deal covers clinical and commercial supplies for patented cyclodextrin  Read More »
Gil Roth
June 20, 2011
Sales team to support PHN treatment Gralise  Read More »
Gil Roth
June 20, 2011
Development candidate to advance in oncology  Read More »
Gil Roth
June 20, 2011
Adds SaaS CTMS platform to offerings  Read More »
Gil Roth
June 20, 2011
Anti-IL-6 MAb goes into Phase IIb  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On